Tirzepatide Side Effects: Low Blood Sugar This mostly affects people taking tirzepatide alongside insulin or sulfonylureas
Figure 4 Safety outcomes: nasopharyngitis, urinary tract infection, diarrhea, hypoglycemia, vomiting, nausea SGLT2i compared to placebo Pooled results showed no significant differences between the first line use of SGLT2i and placebo for nasopharyngitis (OR: 1.07, 95% CI: 0.47, 2.42
This happens because serotonin influences the brains reward system, at times reducing the intensity of the reward response to pleasurable activities, including sex
Increased Insulin Secretion: It facilitates enhanced insulin release, supporting lower blood sugar levels and promoting glucose storage as glycogen in the liver and muscles
So as an example, I want to place a higher body mass index or BMI threshold for somebody to be able to get this drug